Also trades as: 0IFK.L (LSE) · $vol 0M
EDIT Smart Money
Editas Medicine, Inc.
1W: -0.8%
1M: -7.0%
3M: -8.4%
YTD: +17.1%
1Y: -34.2%
3Y: -62.7%
5Y: -93.7%
$2.60
+0.20 (+8.33%)
After Hours: $2.54 (-0.06, -2.50%)
Weekly Expected Move ±10.8%
$2
$2
$2
$3
$3
Credit Risk of going bust: higher than 56% of companies Debt: 4.0% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.02 (down 99.3%), Editas Medicine, Inc. would be worth roughly what it owes.
Total debt $15.5M against a stock market value of $368.6M.
Distance to default 4.53 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $7.8M (short-term plus half of long-term), stock volatility 81.2%; Altman Z'' -20.04. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $0.02 (down 99.3%), Editas Medicine, Inc. would be worth roughly what it owes.
Total debt $15.5M against a stock market value of $368.6M.
Distance to default 4.53 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $7.8M (short-term plus half of long-term), stock volatility 81.2%; Altman Z'' -20.04. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
🏦 Institutional Activity
Latest: Q2 2026244
Institutions Holding
+9 vs prior
104.5%
Ownership
+70.54%
36
New
74
Increased
67
Reduced
25
Closed
👔 Insider Trades
25 records| Date | Name | Title | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-09-03 | Parison Amy | officer: svp, chief financial officer | S-Sale | 453 | $3.04 | $1K | Filing |
| 2026-09-03 | Burkly Linda | officer: evp, chief scientific officer | S-Sale | 709 | $3.04 | $2K | Filing |
| 2026-09-03 | O'Neill Gilmore Neil | officer: ceo | S-Sale | 5,124 | $3.04 | $16K | Filing |
| 2026-08-03 | Parison Amy | officer: svp, chief financial officer | S-Sale | 678 | $2.58 | $2K | Filing |
| 2026-07-28 | Burkly Linda | officer: evp, chief scientific officer | S-Sale | 4,928 | $2.67 | $13K | Filing |
| 2026-06-03 | Parison Amy | officer: svp, chief financial officer | S-Sale | 464 | $2.70 | $1K | Filing |
| 2026-06-03 | O'Neill Gilmore Neil | officer: ceo | S-Sale | 15,380 | $2.70 | $42K | Filing |
| 2026-06-03 | Burkly Linda | officer: evp, chief scientific officer | S-Sale | 731 | $2.70 | $2K | Filing |
| 2026-03-03 | Parison Amy | officer: svp, chief financial officer | S-Sale | 474 | $2.02 | $957 | Filing |
| 2026-03-03 | O'Neill Gilmore Neil | officer: ceo | S-Sale | 5,394 | $2.02 | $11K | Filing |
| 2026-03-03 | Burkly Linda | officer: evp, chief scientific officer | S-Sale | 749 | $2.02 | $2K | Filing |
| 2025-12-03 | Parison Amy | officer: svp, chief financial officer | S-Sale | 461 | $2.15 | $993 | Filing |
| 2025-12-03 | Burkly Linda | officer: evp, chief scientific officer | S-Sale | 713 | $2.15 | $2K | Filing |
| 2025-12-03 | O'Neill Gilmore Neil | officer: ceo | S-Sale | 5,603 | $2.15 | $12K | Filing |
| 2025-09-03 | Parison Amy | officer: svp, chief financial officer | S-Sale | 458 | $2.60 | $1K | Filing |
| 2025-09-03 | O'Neill Gilmore Neil | officer: ceo | S-Sale | 5,592 | $2.60 | $15K | Filing |
| 2025-09-03 | Burkly Linda | officer: evp, chief scientific officer | S-Sale | 710 | $2.60 | $2K | Filing |
| 2025-08-07 | Parison Amy | officer: svp, chief financial officer | S-Sale | 679 | $2.58 | $2K | Filing |
| 2025-07-31 | Burkly Linda | officer: evp, chief scientific officer | S-Sale | 5,121 | $2.49 | $13K | Filing |
| 2025-06-03 | Parison Amy | officer: svp, chief financial officer | S-Sale | 446 | $1.72 | $769 | Filing |
| 2025-06-03 | O'Neill Gilmore Neil | officer: ceo | S-Sale | 15,192 | $1.72 | $26K | Filing |
| 2025-06-03 | Burkly Linda | officer: evp, chief scientific officer | S-Sale | 726 | $1.72 | $1K | Filing |
| 2025-03-04 | Lucera Erick | officer: evp, chief financial officer | S-Sale | 4,109 | $1.71 | $7K | Filing |
| 2025-03-04 | O'Neill Gilmore Neil | officer: ceo | S-Sale | 16,632 | $1.71 | $28K | Filing |
| 2025-03-04 | Burkly Linda | officer: evp, chief scientific officer | S-Sale | 2,891 | $1.71 | $5K | Filing |
🏛️ Congressional Trades
18 records| Date | Politician | Chamber | Type | Amount | Filing |
|---|---|---|---|---|---|
| 2023-04-10 | Daniel Goldman | House | Sell | $1,001 - $15,000 | Filing |
| 2021-04-14 | Donald Sternoff Beyer | House | Sell | $1,001 - $15,000 | Filing |
| 2021-03-02 | Donald Sternoff Beyer | House | Sell | $1,001 - $15,000 | Filing |
| 2020-11-17 | Donald Sternoff Beyer | House | Buy | $1,001 - $15,000 | Filing |
| 2020-05-01 | Donald Sternoff Beyer | House | Sell | $1,001 - $15,000 | Filing |
| 2020-04-27 | Donald Sternoff Beyer | House | Sell | $1,001 - $15,000 | Filing |
| 2020-01-27 | Donald Sternoff Beyer | House | Buy | $1,001 - $15,000 | Filing |
| 2020-01-09 | Donald Sternoff Beyer | House | Buy | $1,001 - $15,000 | Filing |
| 2019-12-23 | Donald Sternoff Beyer | House | Buy | $1,001 - $15,000 | Filing |
| 2019-06-04 | Donna Shalala | House | Sell | $1,001 - $15,000 | Filing |
| 2019-03-06 | Donna Shalala | House | Buy | $1,001 - $15,000 | Filing |
| 2019-02-04 | James Inhofe | Senate | Sell | $15,001 - $50,000 | Filing |
| 2019-02-04 | James Inhofe | Senate | Sell | $15,001 - $50,000 | Filing |
| 2019-02-04 | James Inhofe | Senate | Sell | $15,001 - $50,000 | Filing |
| 2019-02-04 | James Inhofe | Senate | Sell | $15,001 - $50,000 | Filing |
| 2019-02-04 | James Inhofe | Senate | Sell | $15,001 - $50,000 | Filing |
| 2017-10-19 | James Inhofe | Senate | Buy | $15,001 - $50,000 | Filing |
| 2017-10-19 | James Inhofe | Senate | Buy | $15,001 - $50,000 | Filing |
🏦 Top Institutional Holders
20 holders| Holder | Shares | Value | Date Reported | Filing | |
|---|---|---|---|---|---|
| TCG Crossover Management, LLC | 11,111,111 | $36M | +11,111,111 | 2026-06-30 | Filing |
| BlackRock, Inc. | 10,589,990 | $34M | +1,326,678 | 2026-06-30 | Filing |
| RA CAPITAL MANAGEMENT, L.P. | 8,889,000 | $29M | +8,889,000 | 2026-06-30 | Filing |
| ADAR1 Capital Management, LLC | 8,889,000 | $29M | +8,889,000 | 2026-06-30 | Filing |
| Commodore Capital LP | 8,889,000 | $29M | +8,889,000 | 2026-06-30 | Filing |
| VANGUARD CAPITAL MANAGEMENT LLC | 6,141,336 | $20M | +1,936,967 | 2026-06-30 | Filing |
| Paradigm Biocapital Advisors LP | 5,586,625 | $18M | +5,586,625 | 2026-06-30 | Filing |
| Opaleye Management Inc. | 3,861,930 | $13M | +1,934,933 | 2026-06-30 | Filing |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 3,598,339 | $12M | +449,769 | 2026-06-30 | Filing |
| Woodline Partners LP | 3,555,497 | $12M | +3,555,497 | 2026-06-30 | Filing |
| Vivo Capital, LLC | 3,555,250 | $12M | +3,555,250 | 2026-06-30 | Filing |
| GordonMD Global Investments LP | 3,127,000 | $10M | +3,127,000 | 2026-06-30 | Filing |
| GOLDMAN SACHS GROUP INC | 2,614,036 | $8M | +2,055,459 | 2026-06-30 | Filing |
| GEODE CAPITAL MANAGEMENT, LLC | 2,569,072 | $8M | +257,283 | 2026-06-30 | Filing |
| RENAISSANCE TECHNOLOGIES LLC | 2,468,919 | $8M | -1,503,241 | 2026-06-30 | Filing |
| Logos Global Management LP | 2,222,000 | $7M | +2,222,000 | 2026-06-30 | Filing |
| STATE STREET CORP | 2,191,803 | $7M | +115,681 | 2026-06-30 | Filing |
| MARSHALL WACE, LLP | 2,037,287 | $7M | +1,826,979 | 2026-06-30 | Filing |
| D. E. Shaw & Co., Inc. | 1,901,002 | $6M | -42,891 | 2026-06-30 | Filing |
| JPMORGAN CHASE & CO | 1,862,494 | $6M | -84,890 | 2026-06-30 | Filing |